Confirmed Preliminary Control Announced Transaction verified Skin Care

E45 acquired by Karo Healthcare

Karo Healthcare agreed to acquire E45, a personal care / skin care & dermocosmetics brand, on Dec 1, 2021.

Preliminary: The transaction value is not yet independently verified.

Transaction summary

Target
E45
Acquirer
Karo Healthcare
Seller
Reckitt
Announced
2021-12-01
Geography
-
Type
Acquisition
Deal type
Control
Stake acquired
-
First added
2026-06-19
Latest update
2026-10-31

Value and multiples

100% enterprise value

GBP 200M

Unverified

100% enterprise value | GBP

Basis: Public source

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

Approx. $267M USD using FX date 2021-11-29 at 1.3331 GBP/USD.

EV / revenue

4.7x

Period not stated

Basis: FundComb estimate

EV / EBITDA

-

EBITDA basis not stated

Basis: FundComb estimate

Basis

  • The 4.7x revenue multiple comes from FundComb’s comps spreadsheet and is not confirmed by a public source; the price, revenue and period behind it are not stated. Karo Healthcare announced its acquisition of a majority stake in E45 from Reckitt in 2021.

Other reviewed estimates

Earlier estimates and their sources.

other reviewed estimate
EV / revenue 4.7x

Source summary

No public source summary has been published for this transaction yet.

Continue your research

Explore more comps →